Bioventus Inc.

Historical 13F Holders

Symbol
BVS
CUSIP
09075A108
All holders as of
Q2 2026
Type
Equity
Class
COM CL A
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 09075A108 since 12/18/2024, largest first.

Filer % of Class Filed
Nantahala Capital Management, LLC 13G/A
9.0% 2/13/2026
Event 12/31/2025
BlackRock, Inc. 13G 5.0% 7/27/2026
Event 6/30/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 4.15 k $56.6 k
2026 Q2 162 59.9 M $567 M
2026 Q1 160 51.1 M $466 M
2025 Q4 152 50.2 M $374 M
2025 Q3 139 49.3 M $330 M
2025 Q2 139 48.5 M $321 M
2025 Q1 151 47.2 M $448 M
2024 Q4 158 45.6 M $478 M
2024 Q3 143 45.2 M $540 M
2024 Q2 112 44.6 M $256 M
2024 Q1 93 35.2 M $183 M
2023 Q4 90 39.6 M $209 M
2023 Q3 72 33.0 M $109 M
2023 Q2 72 32.0 M $92.8 M
2023 Q1 75 31.9 M $34.3 M
2022 Q4 91 32.0 M $83.4 M
2022 Q3 96 35.1 M $246 M
2022 Q2 102 34.0 M $232 M
2022 Q1 109 31.7 M $447 M
2021 Q4 103 31.2 M $452 M
2021 Q3 70 24.8 M $352 M
2021 Q2 55 20.7 M $364 M
2021 Q1 47 21.9 M $334 M